CUE Cue Biopharma
Company Analysis
Latest News
🟢 Cue Biopharma is trading 5% up in after-hours trading with no confirmed catalyst
Cue Biopharma is trading at $19.62, up +5.09%, in after-hours trading, with no confirmed company-specific catalyst identified. - The move follows a...
🔴 Cue Biopharma is trading 5.5% down — cause unconfirmed
Cue Biopharma is trading 5.5% down at $17.58; no confirmed company-specific catalyst for the decline has emerged. - Reports published October 15 covered...
🟢 Cue Biopharma is trading 8% up in pre-market
Cue Biopharma is trading at $20.00, up +7.53% in pre-market; no confirmed company-specific catalyst was found. - Positive CUE-221 Phase 2 results were...
🔴 Cue Biopharma is trading 5% down today amid sector weakness; company-specific cause unconfirmed
Cue Biopharma is trading 5.01% down at $18.59 on October 14, amid biotech-sector weakness and a broader selloff; no direct cause is confirmed. - XBI is down...
🟢 Cue Biopharma is trading 12.37% up in pre-market
Cue Biopharma is trading at $21.99, up 12.37% in pre-market, with no confirmed company-specific news or overnight catalyst identified to explain the move. -...
🟢 Cue Biopharma is trading 6.2% up in pre-market
Cue Biopharma is trading at $20.78, up 6.18% in pre-market, with no confirmed company-specific catalyst identified. - The move follows a 20.48% decline to...
🟢 Cue Biopharma is trading 6.3% up in after-hours trading
Cue Biopharma is trading 6.3% higher after hours at $20.80, with no confirmed company-specific catalyst. - On October 13, shares fell 20.48% during the regular...
🔴 Cue Biopharma is trading 10% down with no confirmed company-specific explanation
Cue Biopharma is trading 10.08% lower at $22.13 on October 13, 2026, with no confirmed company-specific announcement explaining the decline. - B. Riley’s Buy...
🔴 Cue Biopharma is trading 5.2% down as biotech sector falls; no confirmed company-specific catalyst
Cue Biopharma is trading 5.16% down at $23.34, with the broader biotech sector’s decline potentially contributing; no confirmed company-specific announcement...
🟢 Cue Biopharma is trading 5.65% up in pre-market with no confirmed catalyst
Cue Biopharma is trading at $26.00, up 5.65%, in pre-market, with the reason for the move unconfirmed. - Cue Biopharma closed at $24.61 on October 12,...
🔴 Cue Biopharma is trading 10% down with no clear company-specific catalyst
Cue Biopharma is trading 10.25% down at $24.82, with no clear company-specific catalyst identified for the October 12 decline. - Cue Biopharma’s...
🔴 Cue Biopharma is trading 5.6% down; no clear catalyst identified
Cue Biopharma is trading at $26.10, down 5.64%, with no clear catalyst identified for the October 12 decline. - No company-specific announcement or clear...
🟢 Cue Biopharma is trading 12% up with no identified company-specific catalyst
Cue Biopharma is trading at $25.00, up 11.96%, with no clear company-specific announcement identified to explain the October 9 move. - Recent CUE-221 trial...
🟢 Cue Biopharma is trading 6.6% up; immediate catalyst remains unclear
Cue Biopharma is trading at $23.81, up 6.63%, with no clear immediate catalyst identified for the October 9 move. - No company-specific announcement...
🔴 Cue Biopharma is trading 5.5% down amid biotech-sector weakness
Cue Biopharma is trading 5.5% down at $23.01 on October 6, 2026; biotech-sector weakness may be contributing, though no clear company-specific catalyst was...
🔴 Cue Biopharma is trading 11% down with no identified company-specific catalyst
Cue Biopharma is trading 11.03% lower at $22.75 on October 5, 2026; no company-specific announcement explaining the decline was identified. - The company’s...
🔴 Cue Biopharma is trading 6.8% down
Cue Biopharma is trading at $23.82, down 6.84%, with no clear company-specific announcement explaining the October 5 decline. - Available company news...
🟢 Cue Biopharma is trading 5.5% up with no confirmed catalyst
Cue Biopharma is trading at $26.92, up 5.53%, with no confirmed explanation for the September 30, 2026 move. - No new company-specific announcement explaining...
🔴 Cue Biopharma is trading 10% down; no clear catalyst identified
Cue Biopharma is trading 10.31% lower at $24.62, with no clear company-specific catalyst identified for the September 29 decline. - Positive CUE-221 Phase 2...
🔴 Cue Biopharma is trading 5% down with no clear catalyst identified
Cue Biopharma is trading 5.17% lower at $26.03; no company-specific announcement or clear catalyst was identified for the September 29 decline. - Positive...